Banyan Biomarkers Inc - Product Pipeline Analysis, 2017 Update

  • ID: 4372816
  • Company Profile
  • 37 pages
  • GlobalData
1 of 5

FEATURED COMPANIES

  • Beacon Sciences LLC
  • Exagen Diagnostics Inc
  • Population Bio Inc
  • MORE
Summary

Banyan Biomarkers Inc (Banyan Biomarkers) is a medical technology company that commercializes vitro diagnostic tests for the detection of traumatic brain injury and neurological diseases. The company’s product pipeline includes biomarkers for depression, hypoxic ischemic encephalopathy, neuro ICU monitoring, sub acute or chronic traumatic brain injury, and stroke. Its biomarker includes cellular components, proteins, and physiologic or imaging findings that relate to a disease or injury. Banyan Biomarkers products are tested using enzyme-linked immunosorbent assay’s. The company also provides a point of care diagnostic blood test to detect the presence of mild and moderate brain trauma of head injured patients. It operates in California and Florida. Banyan Biomarkers is headquartered in Alachua, Florida, the US.

This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:
  • The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
  • The report analyzes all pipeline products in development for the company Banyan Biomarkers Inc
  • The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
  • The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
  • The report provides detailed description of products in development, technical specification and functions
  • The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.
Reasons to Buy:
  • Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
  • Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
  • To formulate effective Research & Development strategies
  • Develop market-entry and market expansion strategies
  • Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
  • Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
  • Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Note: Some sections may be missing if data is unavailable for the company.
READ MORE
Note: Product cover images may vary from those shown
2 of 5

FEATURED COMPANIES

  • Beacon Sciences LLC
  • Exagen Diagnostics Inc
  • Population Bio Inc
  • MORE
  • Banyan Biomarkers Inc Company Overview
  • Banyan Biomarkers Inc Company Snapshot
  • Banyan Biomarkers Inc Pipeline Products and Ongoing Clinical Trials Overview
  • Banyan Biomarkers Inc - Pipeline Analysis Overview
  • Banyan Biomarkers Inc - Key Facts
  • Banyan Biomarkers Inc - Major Products and Services
  • Banyan Biomarkers Inc Pipeline Products by Development Stage
  • Banyan Biomarkers Inc Pipeline Products Overview
  • Banyan UCH-L1/GFAP Detection Assay
  • Banyan UCH-L1/GFAP Detection Assay Product Overview
  • Diagnostic Assay - Alcoholism
  • Diagnostic Assay - Alcoholism Product Overview
  • Diagnostic Assay - Alzheimer's Disease
  • Diagnostic Assay - Alzheimer's Disease Product Overview
  • Diagnostic Assay - Amyotrophic Lateral Sclerosis
  • Diagnostic Assay - Amyotrophic Lateral Sclerosis Product Overview
  • Diagnostic Assay - Depression
  • Diagnostic Assay - Depression Product Overview
  • Diagnostic Assay - Huntington’s Disease
  • Diagnostic Assay - Huntington’s Disease Product Overview
  • Diagnostic Assay - Hypoxic Ischemic Encephalopathy
  • Diagnostic Assay - Hypoxic Ischemic Encephalopathy Product Overview
  • Diagnostic Assay - Neural Apoptosis
  • Diagnostic Assay - Neural Apoptosis Product Overview
  • Diagnostic Assay - Neuro ICU Monitoring
  • Diagnostic Assay - Neuro ICU Monitoring Product Overview
  • Diagnostic Assay - Neurodegenerative Diseases
  • Diagnostic Assay - Neurodegenerative Diseases Product Overview
  • Diagnostic Assay - Neurogenesis
  • Diagnostic Assay - Neurogenesis Product Overview
  • Diagnostic Assay - Parkinson's Disease
  • Diagnostic Assay - Parkinson's Disease Product Overview
  • Diagnostic Assay - Seizure
  • Diagnostic Assay - Seizure Product Overview
  • Diagnostic Assay - Stroke
  • Diagnostic Assay - Stroke Product Overview
  • Diagnostic Test - Shaken Baby Syndrome (SBS)
  • Diagnostic Test - Shaken Baby Syndrome (SBS) Product Overview
  • Banyan Biomarkers Inc - Key Competitors
  • Banyan Biomarkers Inc - Key Employees
  • Banyan Biomarkers Inc - Locations And Subsidiaries
  • Head Office
  • Other Locations & Subsidiaries
  • Recent Developments
  • Banyan Biomarkers Inc, Recent Developments
  • Mar 06, 2017: Herb Boyer, PhD and Frederic Sweeney, PhD Join Banyan Biomarkers’ Board of Directors
  • Nov 05, 2015: Banyan Biomarkers Reports Successful Clinical Trial Results of Blood Test to Evaluate Mild and Moderate Traumatic Brain Injury
  • Aug 04, 2011: Banyan Works With Emory University To Analyze Biomarkers In Clinical Trial Of Progesterone In TBI
  • Oct 05, 2010: Banyan Biomarkers Receives $26.3 Million Contract To Develop Diagnostic Test For TBI
  • Aug 09, 2010: Banyan Biomarkers Appoints Lynda Hague As Vice President Of Clinical And Regulatory Affairs
  • Feb 08, 2010: Banyan Biomarkers Appoints Jackson Streeter As CEO And CMO
  • Oct 08, 2007: Banyan Biomarkers Announces Senior Management Appointments
  • Apr 03, 2007: Banyan Biomarkers Appoints Two New Board Members
  • Appendix
  • Methodology
  • About
  • Contact
  • Disclaimer
List of Tables
  • Banyan Biomarkers Inc Pipeline Products and Ongoing Clinical Trials Overview
  • Banyan Biomarkers Inc Pipeline Products by Equipment Type
  • Banyan Biomarkers Inc Pipeline Products by Indication
  • Banyan Biomarkers Inc, Key Facts
  • Banyan Biomarkers Inc, Major Products and Services
  • Banyan Biomarkers Inc Number of Pipeline Products by Development Stage
  • Banyan Biomarkers Inc Pipeline Products Summary by Development Stage
  • Banyan UCH-L1/GFAP Detection Assay - Product Status
  • Banyan UCH-L1/GFAP Detection Assay - Product Description
  • Diagnostic Assay - Alcoholism - Product Status
  • Diagnostic Assay - Alcoholism - Product Description
  • Diagnostic Assay - Alzheimer's Disease - Product Status
  • Diagnostic Assay - Alzheimer's Disease - Product Description
  • Diagnostic Assay - Amyotrophic Lateral Sclerosis - Product Status
  • Diagnostic Assay - Amyotrophic Lateral Sclerosis - Product Description
  • Diagnostic Assay - Depression - Product Status
  • Diagnostic Assay - Depression - Product Description
  • Diagnostic Assay - Huntington’s Disease - Product Status
  • Diagnostic Assay - Huntington’s Disease - Product Description
  • Diagnostic Assay - Hypoxic Ischemic Encephalopathy - Product Status
  • Diagnostic Assay - Hypoxic Ischemic Encephalopathy - Product Description
  • Diagnostic Assay - Neural Apoptosis - Product Status
  • Diagnostic Assay - Neural Apoptosis - Product Description
  • Diagnostic Assay - Neuro ICU Monitoring - Product Status
  • Diagnostic Assay - Neuro ICU Monitoring - Product Description
  • Diagnostic Assay - Neurodegenerative Diseases - Product Status
  • Diagnostic Assay - Neurodegenerative Diseases - Product Description
  • Diagnostic Assay - Neurogenesis - Product Status
  • Diagnostic Assay - Neurogenesis - Product Description
  • Diagnostic Assay - Parkinson's Disease - Product Status
  • Diagnostic Assay - Parkinson's Disease - Product Description
  • Diagnostic Assay - Seizure - Product Status
  • Diagnostic Assay - Seizure - Product Description
  • Diagnostic Assay - Stroke - Product Status
  • Diagnostic Assay - Stroke - Product Description
  • Diagnostic Test - Shaken Baby Syndrome (SBS) - Product Status
  • Diagnostic Test - Shaken Baby Syndrome (SBS) - Product Description
  • Banyan Biomarkers Inc, Key Employees
  • Banyan Biomarkers Inc, Other Locations
  • Glossary
List of Figures
  • Banyan Biomarkers Inc Pipeline Products by Equipment Type
  • Banyan Biomarkers Inc Pipeline Products by Development Stage
Note: Product cover images may vary from those shown
3 of 5

Loading
LOADING...

4 of 5
  • Stemina Biomarker Discovery Inc
  • Population Bio Inc
  • Integrated Diagnostics Inc
  • Exagen Diagnostics Inc
  • Beacon Sciences LLC
Note: Product cover images may vary from those shown
5 of 5
Note: Product cover images may vary from those shown
Adroll
adroll